Phase Therapeutics is comprised of a team of leading experts in cryomedicine and proven commercialization partners of Lung & GI endoscopy innovations. Our mission is to improve the standards of care for lung and pancreatic cancer treatment and directly impact survival rates. We have developed the 1st and only tumor ablation platform unlocking the translumenal delivery of ultracold cryoablation.  Our technology is an innovative combination of a novel mixed-phase cryogen (Pressurized sub-cooled nitrogen) compatible with Endobrochial Ultrasound (EBUS), Robotic-Assisted Bronchoscopy (RAB), and Endoscopic Ultrasound (EUS) delivery.  Contact us to engage in this transformative medical device opportunity.

Phase Therapeutics

Org chart

Teams

Offices